by Dolly the Sheep | Jun 24, 2026 | Disease Modelling, Drug Discovery, Immunology, in vivo Studies
ARTICLE BY BIO X CELL Factors That Influence Antibody Performance In Vivo Bio X Cell has recently published an insightful guide titled “Factors That Influence Antibody Performance In Vivo,” addressing a critical hurdle in preclinical and translational research. As...
by Dolly the Sheep | Jun 24, 2026 | Disease Modelling, Drug Discovery, Immunology, in vivo Studies
ARTICLE BY BIO X CELL Emerging Therapeutic Strategies in Cancer Research Bio X Cell has recently published a comprehensive piece titled “Emerging Therapeutic Strategies in Cancer Research.” Oncology is transitioning into a new era defined by precision, biological...
by Dolly the Sheep | Jun 24, 2026 | Disease Modelling, Drug Discovery, Immunology, in vivo Studies
ARTICLE BY BIO X CELL Bio X Cell Introduces First Commercially Available Anti-Mouse Trispecific Antibody for Preclinical Research Bio X Cell has announced the launch of the first commercially available, ready-to-use anti-mouse PD-L1 × TIGIT × LAG3 trispecific antibody...
by Dolly the Sheep | Jun 24, 2026 | Disease Modelling, Drug Discovery, Immunology, in vivo Studies
ARTICLE BY BIO X CELL The Reproducibility Crisis Is a Reagent Crisis For more than a decade, concerns regarding scientific reproducibility have echoed across funding agencies, academic journals, and research laboratories worldwide. While investigators typically...
by Dolly the Sheep | Jun 24, 2026 | Disease Modelling, Drug Discovery, Immunology, in vivo Studies
ARTICLE BY BIO X CELL How Fc Engineering Improves Mechanistic Clarity in In Vivo Studies Bio X Cell has recently published a highly informative piece titled “How Fc Engineering Improves Mechanistic Clarity in In Vivo Studies.” As researchers transition their work from...
